{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T04:30:46Z","timestamp":1769574646257,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["108-001"],"award-info":[{"award-number":["108-001"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Australasian Emergency Care"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.auec.2021.11.004","type":"journal-article","created":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T01:25:25Z","timestamp":1637630725000},"page":"224-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Overview of drug treatment for paroxysmal supraventricular tachycardia in Taiwan emergency departments: Adenosine using trend from 2000 to 2012"],"prefix":"10.1016","volume":"25","author":[{"given":"Ya-Hsin","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Chang","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Chang","family":"Hung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuei-Chuan","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Chin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen Yi","family":"Chao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan-Wen","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.auec.2021.11.004_bib1","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1056\/NEJMcp051145","article-title":"Clinical practice. Supraventricular tachycardia","volume":"354","author":"Delacr\u00e9taz","year":"2006","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.auec.2021.11.004_bib2","first-page":"e471","volume":"133","author":"Page","year":"2016","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.auec.2021.11.004_bib3","first-page":"942","article-title":"Common types of supraventricular tachycardia: diagnosis and management","volume":"82","author":"Colucci","year":"2010","journal-title":"Am Fam Physician"},{"issue":"1","key":"10.1016\/j.auec.2021.11.004_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1460-9592.2001.00041.x","article-title":"Paroxysmal tachycardia in children and teenagers with normal sinus rhythm and without heart disease","volume":"24","author":"Brembilla-Perrot","year":"2001","journal-title":"Pacing Clin Electro"},{"issue":"1","key":"10.1016\/j.auec.2021.11.004_bib5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0735-1097(97)00422-1","article-title":"Paroxysmal supraventricular tachycardia in the general population","volume":"31","author":"Orejarena","year":"1998","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.auec.2021.11.004_bib6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0002-9149(92)90196-6","article-title":"Acute conversion of paroxysmal supraventricular tachycardia with intravenous diltiazem. IV Diltiazem Study Group","volume":"70","author":"Dougherty","year":"1992","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.auec.2021.11.004_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0196-0644(98)70277-X","article-title":"Comparison of treatment of supraventricular tachycardia by Valsalva maneuver and carotid sinus massage","volume":"31","author":"Lim","year":"1998","journal-title":"Ann Emerg Med"},{"issue":"5","key":"10.1016\/j.auec.2021.11.004_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.5694\/j.1326-5377.2009.tb02388.x","article-title":"Supraventricular tachycardia","volume":"190","author":"Medi","year":"2009","journal-title":"Med J Aust"},{"issue":"4","key":"10.1016\/j.auec.2021.11.004_bib9","first-page":"586","article-title":"Current trends in supraventricular tachycardia management","volume":"14","author":"Sohinki","year":"2014","journal-title":"Ochsner J"},{"issue":"2","key":"10.1016\/j.auec.2021.11.004_bib10","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s002469900129","article-title":"Adenosine: an effective and safe antiarrhythmic drug in pediatrics","volume":"18","author":"Paul","year":"1997","journal-title":"Pedia Cardiol"},{"issue":"3","key":"10.1016\/j.auec.2021.11.004_bib11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1017\/S1049023X00037663","article-title":"Adenosine for the treatment of PSVT in the prehospital arena: efficacy of an initial 6 mg dosing regimen","volume":"12","author":"Wittwer","year":"1997","journal-title":"Prehosp Disaster Med"},{"issue":"6","key":"10.1016\/j.auec.2021.11.004_bib12","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/01.CIR.68.6.1254","article-title":"Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia","volume":"68","author":"DiMarco","year":"1983","journal-title":"Circulation"},{"key":"10.1016\/j.auec.2021.11.004_bib13","unstructured":"ACLS\/PALS LM. Discussion forums on adenosine dosage recommended by the American Heart Association guidelines 2019. Available from: \u3008https:\/\/acls-algorithms.com\/acls-drugs\/acls-and-adenosine\/comment-page-6\/#comment-572598\u3009."},{"key":"10.1016\/j.auec.2021.11.004_bib14","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2018062","article-title":"Data resource profile: the National Health Insurance Research Database (NHIRD)","volume":"40","author":"Lin","year":"2018","journal-title":"Epidemiol Health"},{"key":"10.1016\/j.auec.2021.11.004_bib15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2147\/CLEP.S196293","article-title":"Taiwan\u2019s National Health Insurance Research Database: past and future","volume":"11","author":"Hsieh","year":"2019","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.auec.2021.11.004_bib16","unstructured":"National Health Insurance Research Database. Data subsets."},{"issue":"3","key":"10.1016\/j.auec.2021.11.004_bib17","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/pds.2087","article-title":"Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan","volume":"20","author":"Cheng","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.auec.2021.11.004_bib18","series-title":"Vagal Maneuver. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2021","author":"Niehues","year":"2021"},{"issue":"2","key":"10.1016\/j.auec.2021.11.004_bib19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7326\/0003-4819-113-2-104","article-title":"Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group","volume":"113","author":"DiMarco","year":"1990","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.auec.2021.11.004_bib20","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jemermed.2015.11.012","article-title":"High-dose adenosine for treatment of refractory supraventricular tachycardia in an emergency department of an academic medical center: a case report and literature review","volume":"50","author":"Bailey","year":"2016","journal-title":"J Emerg Med"},{"key":"10.1016\/j.auec.2021.11.004_bib21","unstructured":"LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012."},{"issue":"11","key":"10.1016\/j.auec.2021.11.004_bib22","first-page":"2189","article-title":"Amiodarone: guidelines for use and monitoring","volume":"68","author":"Siddoway","year":"2003","journal-title":"Am Fam Physician"}],"container-title":["Australasian Emergency Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588994X21000798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588994X21000798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:56:57Z","timestamp":1762876617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588994X21000798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S2588994X21000798"],"URL":"https:\/\/doi.org\/10.1016\/j.auec.2021.11.004","relation":{},"ISSN":["2588-994X"],"issn-type":[{"value":"2588-994X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overview of drug treatment for paroxysmal supraventricular tachycardia in Taiwan emergency departments: Adenosine using trend from 2000 to 2012","name":"articletitle","label":"Article Title"},{"value":"Australasian Emergency Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.auec.2021.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 College of Emergency Nursing Australasia. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}